Companies on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Vivus, Inc.

Vivus (or 'the company') is a biopharmaceutical company focused on research, development and commercialization of products in the areas of sexual health, obesity and diabetes. The company primarily operates in the US. Vivus is headquartered in Mountain View, California, and employed 98 people as of February 19, 2014.

Published By MarketLine
30 Jun 2014 $175
Buy
Company Profile
Company Profile

INC Research, LLC

INC Research (or 'the company') is a contract research organization (CRO) specializing in providing clinical trials services. The company offers therapeutic clinical trial expertise across a variety of indications, as well as for special populations, such as women and pediatrics. It operates in the Americas, Europe, the Middle East, Asia Pacific and Africa. The company is headquartered in Raleigh, North Carolina, and employs about 5,000 people.

Published By MarketLine
16 Jul 2014 $175
Buy
Company Profile
Company Profile

Kyowa Hakko Kirin Co., Ltd.

Kyowa Hakko Kirin (KHK or 'the group') is a Japan-based provider of pharmaceuticals and bio-chemicals. The group is a subsidiary of Kirin Holdings Company, which holds 50.1% of KHK's shares. The group is headquartered in Tokyo, Japan, and employed 7,152 people as on December 31, 2013.

Published By MarketLine
18 Jul 2014 $175
Buy
Company Profile
Company Profile

Krka, d. d., Novo mesto

Krka, d. d., Novo mesto (Krka or 'the group'), is a Slovenia-based provider of prescription pharmaceuticals, self-medication products, and animal health products. The group is also engaged in the health resort business and providing tourist services. The group primarily operates in Europe. It is headquartered in Novo Mesto, Slovenia and employed 10,048 people as of December 31, 2013.

Published By MarketLine
18 Jul 2014 $175
Buy
Company Profile
Company Profile

Boehringer Ingelheim GmbH

Boehringer Ingelheim (BI or 'the group') is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. BI employed 47,492 people in 2013.

Published By MarketLine
18 Jul 2014 $175
Buy
Company Profile
Company Profile

Celesio AG

Celesio (or 'the group') is a leading wholesale and retail distributor of pharmaceuticals. It primarily operates in Germany and other European countries such as Austria, the Czech Republic, Italy, Belgium, the UK, Ireland and France. Celesio is headquartered in Stuttgart, Germany, and employed 28,653 people as of December 31, 2013.

Published By MarketLine
23 Jul 2014 $175
Buy
Company Profile
Company Profile

Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc. (Idenix or 'the company'), a development-stage biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of human viral diseases. The company's current focus is on the treatment of hepatitis C virus (HCV) infections. Idenix operates in the US and France. It is headquartered in Cambridge, Massachusetts, and employed 84 people as of December 31, 2013.

Published By MarketLine
24 Jul 2014 $175
Buy
Company Profile
Company Profile

Omnicare, Inc

Omnicare (or 'the company') is a leading geriatric pharmaceutical services company in the US. The company also provides specialty pharmacy and commercialization services for the biopharmaceutical industry. Omnicare operates in the US. It is headquartered in Cincinnati, Ohio, and employed about 13,900 people, including approximately 900 part-time employees, as of December 31, 2013.

Published By MarketLine
13 Aug 2014 $175
Buy
Company Profile
Company Profile

UCB S.A.

UCB (or 'the company') is a global biopharmaceutical company focused on the discovery and development for people living with severe diseases of the immune system or of the central nervous system (CNS). It has operations in about 40 countries across Europe, North America and Asia Pacific. It is headquartered in Brussels, Belgium, and employed 8,732 people as of December 31, 2013.

Published By MarketLine
14 Aug 2014 $175
Buy
Company Profile
Company Profile

GTx, Inc.

GTx (or 'the company') is a biopharmaceutical company engaged in the development and commercialization of small molecules that target hormone pathways to treat cancer and cancer-related muscle wasting, cancer supportive care, and other serious medical conditions. The company operates in the US where it is headquartered in Memphis, Tennessee. GTx employed 32 people as on December 31, 2013.

Published By MarketLine
14 Aug 2014 $175
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.